Serum high density lipoprotein (HDL) cholesterol was measured in non-diabetic and diabetic men and women by ultracentrifugation, heparin-manganese chloride precipitation (heparin/ Mn++), and sodium phosphotungstate-magnesium chloride precipitation (PT/Mg++). Results of the three methods were closely correlated in both diabetics and non-diabetics. Concentrations were, however, generally lowest by PT/Mg+ + , intermediate by ultracentrifugation, and highest by heparin/ Mn" +. These differences were of small magnitude except in the case of diabetic patients treated with insulin. In these patients, serum HDL cholesterol levels were significantly greater than those of nondiabetic patients when measured by heparln/Mn" " and ultracentrifugation, but not by PT/Mg++' This was explained by the finding that the discrepancy between PTjMg+ + and ultracentrifugation increased with increasing HDL cholesterol concentration.
Material and methods

SUBJECTS AND SER UM SAMPLES
The patients studied were 63 men and women attending the Diabetic Clinic at the Manchester Royal Infirmary. Ofthese, 42 (19 men and 23 women) aged 41 ± 2 years (mean ± SEM) were receiving treatment with insulin either because of a previous episode of diabetic ketoacidosis or because of failure of adequate control with diet and oral hypoglycaemic drugs. Twenty-one (9 men and 12 women) aged 53 ± 4 years were receiving treatment by diet alone or by diet and oral hypoglycaemic drugs. The duration of treatment was 13 ± 1 years in the insu1intreated patients and 5 ± 1 years in the patients treated without insulin. The non-diabetic volunteers were 1S men and 18 women aged 4S ± 3 years working in the hospital or at a nearby factory. Venous blood was collected non-fasting between 1330 and 1430 from all the subjects studied. Serum HDL cholesterol was determined by each of the three methods in all 96 subjects.
UL TRACENTRIF VO AT ION Three millilitres of serum were adjusted to a density of 1·063 gjml and 2 ml to a density of 1·125 g/ml,13 and the ultracentrifuge tubes were filled with solutions of similar density. After ultracentrifugation at 100 OOOg for 48 hours (Superspeed 65 with 18 X 199 ·Present address and address for correspondence: Division of Metabolic Disease, M-013D, Department of Medicine, University of California, San Diego, La Jolla, California 92093, USA.
There are conflicting reports concerning the concentration of serum high density lipoprotein (HDL) cholesterol in diabetes mellitus. Some workers find higher than normal levels in insulin-treated diabetic patients,!1 whereas others find normals--s or even low levels. s In part this may be due to differences in the degree to which the diabetes was controlled and to differences in the non-diabetic populations with whom the diabetic patients were compared.s 7 However, there have also been differences in the methods used to isolate HDL from serum. Three methods have been used: ultracentrifugation," precipitation with heparin-manganese chloride (heparinfMn+ +)1145 and sodium phosphotungstate-magnesium chloride (PTfMg+ +). 3 6 These methods have been compared previously in non-diabetics'c'-? and in a mixed group of diabetic and normal subjects." However, recently attention has been drawn to the lower levelsof serum HDL cholesterol in reports in which the PT fMg+ + method has been used as compared to those in which the heparin/Mn + + method was used.P In the present report, concentrations of serum HDL cholesterol isolated by ultracentrifugation, heparinf Mn + + precipitation, and PT IMg + + precipitation from normal subjects and from diabetic patients were compared. 6·5 ml Aluminium Rotor, MSE Ltd, Crawley, Sussex, UK) the infranatant was isolated by tubeslicing (Spinco Tube Slicer, Beckman Instruments Inc, Palo Alto, California, USA). The cholesterol concentration of the infranatant at density 1·063 g/ml was regarded as total HDL cholesterol and that at density 1·125 glml as HDL. cholesterol. HDL. cholesterol concentration was obtained by difference.
STATISTICAL ANALYSIS
Significant differences at or below the 5 % level between non-diabetic subjects, diabetic patients treated with insulin, and diabetic patients treated by other means were sought by one-way analysis of variance and Duncan's procedure and between men and women by Student's t test.
Results ·Significantly greater than male counterpart•. tSianificantly il"eater than non-diabetic subjects. SERUM HDL CHOLESTEROL CONCENTRATION The serum HDL cholesterol concentrations in nondiabetic women and diabetic women receiving treatment with insulin were significantly higher than in their male counterparts by all three methods (Table  I) . By none of the three methods was there a significant difference between male and female diabetic patients treated without insulin. In all the groups of diabetic and non-diabetic men and women studied, the mean serum HDL cholesterol concentration determined by PT /Mg+ + was lower than by either ultracentrifugation or heparin/ Mn" +. With the exception of diabetic men not receiving insulin treatment, the mean concentrations of serum HDL cholesterol by heparin/Mn" " were higher than those obtained by ultracentrifugation.
There were no significant differences between the concentrations of serum HDL cholesterol in diabetic men and women not treated with insulin and normal men and women by any of the methods. The serum HDL cholesterol levels in diabetic men and women treated with insulin were significantly higher than those of non-diabetic men and women when meassured by heparin/Mn" + and by ultracentrifugation, but when measured by PT IMg+ + no clear difference between insulin-treated diabetics and non-diabetics was observed. BLOOD GLUCOSE AND HAEMOGLOBIN Al Blood sugar was measured by the automated glucoseoxidase method in routine use at the hospital. Haemoglobin Al (HbA 1 ) was determined as an index of diabetic control in the diabetic patients and in the non-diabetic volunteers for comparison. Whole blood collected in EDTA was analysed within 24 hours of collection using a method previously validated by Abraham et at. 19 (Table 3 ). Serum cholesterol concentrations were similar in diabetics and non-diabetics. Serum L-particle concentrations were significantly higher in insulin-treated diabetic women than in non- Table 2 ).
In non-diabetic subjects the total serum HDL cholesterol concentration measured by either precipitation method was closely correlated with serum HDL. cholesterol concentration, but much less so with serum HDL. cholesterol. In diabetic patients, however, both serum HDL I and HDL. cholesterol concentrations were closely correlated with total serum HDL cholesterol concentration determined by either precipitation method.
In order to assess whether the difference in serum HDL cholesterol concentration as determined by precipitation methods or by ultracentrifugation was dependent on the serum HDL concentration, the differences were plotted against the concentration obtained by ultracentrifugation (Figs 1 and 2) . The difference between PT /Mg+ + and ultracentrifugation was positively correlated with the serum HDL cholesterol concentration. and there was no significant difference between the slope of the regression lines for diabetics and non-diabetics ( Fig. 1 ). There was no clear relationship between the difference in serum HDL cholesterol by heparin/ Mn ++ and ultracentrifugation and the concentration of serum HDL cholesterol concentration (Fig. 2) . 
·Significantly different from that in non-diabetic subjects.
diabetic women or in diabetic women not treated with insulin. They were similar in all groups of men. All groups of diabetic patients had significantly greater concentrations of serum M-particles than non-diabetic men or women.
CORRELATION OF SERUM HDL CHOLESTEROL CONCENTRATIONS WITH OTHER LIPOPROTEINS
By none of the methods was serum HDL cholesterol concentration correlated with the concentration of serum L-particles (Table 3) or serum M-particles.
Discussion
The present study has shown that serum HDL cholesterol concentrations are highest when measured by heparinj'Mn" +, intermediate by ultracentrifugation, and lowest by PT jMg+ +. Of the groups studied, the differences were most marked in the insulintreated diabetic patients. The disparity in the results obtained by PT jMg+ + and ultracentrifugation, however, appeared to increase with increasing HDL concentration in both diabetic and non-diabetic men and women. The statistical significance of the increased concentrations of serum HDL cholesterol in diabetic patients treated with insulin was lost when measured by PT jMg+ + ; this finding is similar to that of Calvert et al., 3 whereas the raised levels of serum HDL cholesterol in insulin-treated diabetics measured by ultracentrifugation and heparin/Mn" + confirm reports in which these methods were used. I I Measurement of serum HDL cholesterol by ultracentrifugation is likely to differ from the other methods because the lipoprotein fraction isolated includes part of the apolipoprotein B-containing lipoprotein designated Lp(a) present in the density range 1·055-1·085 gjml. 20 In normal serum this lipoprotein probably makes only a small contribution to the cholesterol concentration. Its level in the serum of diabetic patients and thus its effect on serum HDL cholesterol levels measured by ultracentrifugation is unknown.
Serum HDL cholesterol concentrations were consistently higher when determined by heparin/Mn" + than by ultracentrifugation. However, the difference between the two methods was not concentrationdependent, which suggests that this method is preferable to the PT jMg+ + method. The finding also suggests that, in addition to lipoproteins of density > 1.063 gjml, the HDL isolated by the heparin/ Mn ++ method also includes lipoproteins of lower density, particularly in insulin-treated patients. Methods for the isolation of HDL involving polyanions, such as heparin and phosphotungstate, are generally considered to precipitate chylomicrons, VLDL, and LDL, by binding to their apolipoprotein B moiety. It has, however, previously been shown that concentrations of apolipoprotein B in the' supernatant after precipitation of serum lipoproteins with heparin-Mn" + is not greater in insulin-treated diabetic patients than in diabetics treated without insulin or non-diabetics," Thus, the higher levels of serum HDL cholesterol found when using this method may be due either to the presence in the supernatant of low density lipoproteins containing apolipoproteins other than apolipoprotein B or, in the case of insulin-treated diabetics, to the presence of apolipoprotein B-containing lipoproteins richer in cholesterol than those remaining in the supernatant obtained from non-diabetics or diabetics receiving other types of therapy. It hils recently been reported that HDL isolated by heparin/Mn" " contains more apolipoprotein Ethan HDL prepared by ultracentrifugatlon.s-Apolipoprotein E, like apolipoprotein B, has abundant positively charged groups and, with the probable exception of that part of serum apolipoprotein E which is disulphidelinked to apolipoprotein AII/n 23 binds to polyanions. 2 4 25 Variation in the degree of interaction of apolipoprotein E-containing lipoproteins with PT/ Mg+ + and heparinjMn" + has not so far been investigated and may explain some of the differences between the two methods. In addition, lipoproteins normally making only a minor contribution to total serum lipoproteins may be quantitatively increased in diabetes. For example, levels of HDL 1 may be considerably increased in ketoacidotic patients.s" The behaviour of such lipoproteins with polyanions is unknown.
In non-diabetic subjects the serum HDL concentration determined by both precipitation methods was closely correlated with the serum HDL. cholesterol concentration but not with HDL •. This supports the finding of Anderson et al. 2 7 by analytical ultracentrifugation that most of the variation in serum HDL levels in normal people is due to variations in serum HDL. levels. In diabetic patients treated with insulin in the present study, a close correlation betwen total serum HDL cholesterol levels and both HDL. and HDL. concentration was, however, found. This is consistent with the recent finding by ultracentrifugation that in such patients the increase in serum HDL cholesterol concentration was largely due to raised levels of serum HDL. cholesterol (unpublished observations).
. It has been shown previously that in diabetes serum HDL cholesterol concentration depends on the type of diabetes'r" and its degree of controf 3 in addition to the other factors known to influence serum HDL cholesterol in non-diabetic populations, and the present study shows that methods for quantitating serum HDL cholesterol previously applied to largely non-diabetic populations may give very different results in diabetes. Reckless et aP8 have suggested that serum HDL cholesterol levels may be much less important in diabetes than in nondiabetic populations in discriminating between patients with and without vascular disease. Further characterisation of the methods for measuring serum HDL cholesterol concentration, when applied to diabetic patients and prospective studies in welldefined groups of patients, is required before the same prognostic significance can be afforded to levels of serum HDL cholesterol in diabetic populations as in non-diabetic populations.29-31 
